PRAX – praxis precision medicines, inc. (US:NASDAQ)
Stock Stats
News
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $151.00 price target on the stock.
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... [Yahoo! Finance]
Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Mastrocola Lauren
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Kelly Timothy Edwin
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Mastrocola Lauren
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Nemiroff Alex
Form SC 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.